Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.491
+0.001 (0.20%)
At close: Nov 21, 2024, 4:00 PM
0.480
-0.011 (-2.24%)
After-hours: Nov 21, 2024, 6:12 PM EST
Spruce Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 60.06 | 96.34 | 24.49 | 42.75 | 157.15 | 3.92 | Upgrade
|
Short-Term Investments | - | - | 54.59 | 46.22 | - | - | Upgrade
|
Cash & Short-Term Investments | 60.06 | 96.34 | 79.08 | 88.97 | 157.15 | 3.92 | Upgrade
|
Cash Growth | -44.41% | 21.83% | -11.12% | -43.39% | 3904.84% | -4.57% | Upgrade
|
Prepaid Expenses | 2.66 | 3.88 | 3.32 | 2.53 | 2.97 | 0.22 | Upgrade
|
Restricted Cash | - | - | 0.22 | - | - | - | Upgrade
|
Other Current Assets | 0.86 | 1.97 | 1 | 0.4 | 0.28 | 0.51 | Upgrade
|
Total Current Assets | 63.57 | 102.18 | 83.61 | 91.9 | 160.4 | 4.65 | Upgrade
|
Property, Plant & Equipment | 1 | 1.18 | 1.4 | 1.48 | 1.87 | - | Upgrade
|
Long-Term Investments | - | - | - | 32.46 | - | - | Upgrade
|
Other Long-Term Assets | 0.53 | 0.58 | 0.64 | 0.65 | 0.62 | 0.04 | Upgrade
|
Total Assets | 65.1 | 103.95 | 85.65 | 126.49 | 162.88 | 4.69 | Upgrade
|
Accounts Payable | 1.8 | 3.33 | 1.43 | 2.82 | 3.63 | 1.88 | Upgrade
|
Accrued Expenses | 7.74 | 14.35 | 9.26 | 5.69 | 3.33 | 1.17 | Upgrade
|
Current Portion of Long-Term Debt | 1.62 | 1.62 | 1.62 | - | 2.55 | 1.25 | Upgrade
|
Current Portion of Leases | - | 0.25 | 0.14 | 0.36 | 0.25 | - | Upgrade
|
Current Unearned Revenue | 0.7 | 4.91 | - | - | - | - | Upgrade
|
Total Current Liabilities | 11.86 | 24.47 | 12.45 | 8.87 | 9.76 | 4.3 | Upgrade
|
Long-Term Debt | 0.52 | 1.72 | 3.29 | 4.88 | 1.92 | 3.19 | Upgrade
|
Long-Term Leases | 0.81 | 1.02 | 1.26 | 1.29 | 1.65 | - | Upgrade
|
Other Long-Term Liabilities | 0.27 | 0.24 | 0.16 | 0.07 | 0.12 | 0.02 | Upgrade
|
Total Liabilities | 13.46 | 27.44 | 17.16 | 15.12 | 13.46 | 7.52 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 278.34 | 273.74 | 218.35 | 214.69 | 210.27 | 0.66 | Upgrade
|
Retained Earnings | -226.71 | -197.23 | -149.31 | -103.13 | -60.84 | -31.3 | Upgrade
|
Comprehensive Income & Other | - | - | -0.56 | -0.18 | - | - | Upgrade
|
Total Common Equity | 51.64 | 76.51 | 68.49 | 111.37 | 149.43 | -30.64 | Upgrade
|
Shareholders' Equity | 51.64 | 76.51 | 68.49 | 111.37 | 149.43 | -2.82 | Upgrade
|
Total Liabilities & Equity | 65.1 | 103.95 | 85.65 | 126.49 | 162.88 | 4.69 | Upgrade
|
Total Debt | 2.96 | 4.61 | 6.32 | 6.53 | 6.38 | 4.45 | Upgrade
|
Net Cash (Debt) | 57.1 | 91.73 | 72.76 | 82.44 | 150.77 | -0.52 | Upgrade
|
Net Cash Growth | -44.55% | 26.07% | -11.74% | -45.32% | - | - | Upgrade
|
Net Cash Per Share | 1.39 | 2.38 | 3.09 | 3.53 | 25.17 | -0.68 | Upgrade
|
Filing Date Shares Outstanding | 41.3 | 41.15 | 39.75 | 23.49 | 23.3 | 0.77 | Upgrade
|
Total Common Shares Outstanding | 41.3 | 41.03 | 23.6 | 23.49 | 23.26 | 0.76 | Upgrade
|
Working Capital | 51.72 | 77.72 | 71.16 | 83.02 | 150.63 | 0.35 | Upgrade
|
Book Value Per Share | 1.25 | 1.86 | 2.90 | 4.74 | 6.42 | -40.08 | Upgrade
|
Tangible Book Value | 51.64 | 76.51 | 68.49 | 111.37 | 149.43 | -30.64 | Upgrade
|
Tangible Book Value Per Share | 1.25 | 1.86 | 2.90 | 4.74 | 6.42 | -40.08 | Upgrade
|
Machinery | - | - | - | - | 0.06 | - | Upgrade
|
Leasehold Improvements | - | - | - | - | 0.01 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.